Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women
Status:
Withdrawn
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
COVID-19 was declared a pandemic on March 11th. Efforts to save lives are essential as we
will face increasing morbidity with rising demands on health care resources. Since pregnant
women with COVID-19 have systematically been excluded from drug trials, potential treatment
options for these high-risk individuals remain untested. The aim of our trial is to determine
whether hydroxychloroquine given to COVID-19 positive pregnant women can reduce
COVID-19-related hospital admissions, thereby allowing women to stay at home while limiting
utilization of hospital resources and resulting exposure of health care providers.